(Reuters) British Cycling is cooperating fully with an investigation by the country’s anti-doping agency UKAD into “allegations of wrongdoing within cycling”, it said yesterday.
UKAD gave no details of what they were investigating, although a report in the Daily Mail newspaper said it concerned Team Sky and former Tour de France winner Bradley Wiggins.
“In order to protect the integrity of the investigation, we will not comment further,” UKAD said in a statement.
The Daily Mail reported that UKAD was investigating the alleged delivery to team Sky in June 2011 of a medical package after the Dauphine Libere race and ahead of that year’s Tour.
Team Sky said in a statement they had been contacted by the newspaper and immediately conducted an internal review to establish the facts.
“We are confident there has been no wrongdoing,” it added. “We informed British Cycling of the allegation and asked them to contact UKAD, who we will continue to liaise with.
“Team Sky is committed to clean competition. Our position on anti-doping is well known and we 100 percent stand by that.”
In a statement British Cycling said: “British Cycling can confirm there is an ongoing UKAD investigation with which we are cooperating fully.
“We are unable to comment further at this stage.”
Wiggins, the 2012 Tour de France winner, has been in the spotlight over his past use of Therapeutic Use Exemptions (TUEs), which allow athletes to take banned substances for verified medical needs and are signed off by sports federations.
The data was leaked last month by the Russian-based Fancy Bears cyber hacking site.
It showed Wiggins was given permission to have legal injections of the banned drug triamcinolone to treat breathing difficulties before the 2011 and 2012 Tour de France and 2013 Tour of Italy.